Literature DB >> 6777095

Adult GM1 gangliosidosis: clinical and biochemical studies on two patients and comparison to other patients called variant or adult GM1 gangliosidosis.

D A Wenger, M Sattler, O T Mueller, G G Myers, R S Schneiman, G W Nixon.   

Abstract

Two young adult siblings were diagnosed as having a deficiency of acid beta-galactosidase activity in leukocytes and fibroblasts. The parents had enzyme levels approximately half of the normal level, consistent with this being the primary enzymatic lesion. Sialidose activities measured with natural and synthetic substrates in the patient's skin fibroblast cultures were normal. Hybridization of one of these patient's cells with cells from a patient with GM1 gangliosidosis, Type 1 did not show complementation of beta-galactosidase activity. However, when the cells from the patient were hybridized with cells from a patient with combined sialidase and beta-galactosidase deficiency, complementation was observed. These two siblings have ataxia, mild intellectual deterioration, slurred speech, mild vertebral changes and little, if any, visceromegaly. They do not have myoclonus, seizures or cherry-red spots, which are found in most patients with combined sialidase and beta-galactosidase deficiency. These patients are discussed with regard to other patients in the literature called variant or adult GM1 gangliosidosis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6777095     DOI: 10.1111/j.1399-0004.1980.tb00158.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  14 in total

1.  The lesions of an ovine lysosomal storage disease. Initial characterization.

Authors:  R D Murnane; D J Prieur; A J Ahern-Rindell; S M Parish; L L Collier
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

Review 2.  Screening for lysosomal disorders.

Authors:  K Ullrich
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

Review 3.  Ganglioside storage diseases: an updated review.

Authors:  J S O'Brien
Journal:  Ital J Neurol Sci       Date:  1981-08

4.  Lectin histochemistry of an ovine lysosomal storage disease with deficiencies of beta-galactosidase and alpha-neuraminidase.

Authors:  R D Murnane; A J Ahern-Rindell; D J Prieur
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

5.  Type 3 GM1 gangliosidosis: clinical and neuroradiological findings in an 11-year-old girl.

Authors:  R Tanaka; T Momoi; A Yoshida; M Okumura; S Yamakura; Y Takasaki; T Kiyomasu; C Yamanaka
Journal:  J Neurol       Date:  1995-05       Impact factor: 4.849

6.  Mutations in the lysosomal beta-galactosidase gene that cause the adult form of GM1 gangliosidosis.

Authors:  S Chakraborty; M A Rafi; D A Wenger
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

7.  Human beta-galactosidase gene mutations in GM1-gangliosidosis: a common mutation among Japanese adult/chronic cases.

Authors:  K Yoshida; A Oshima; M Shimmoto; Y Fukuhara; H Sakuraba; N Yanagisawa; Y Suzuki
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

8.  The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents.

Authors:  Markus Ries; Uma Ramaswami; Rossella Parini; Bengt Lindblad; Catharina Whybra; Ingrid Willers; Andreas Gal; Michael Beck
Journal:  Eur J Pediatr       Date:  2003-09-20       Impact factor: 3.183

9.  GM1 gangliosidosis, type 2: ocular clinicopathologic correlation.

Authors:  L J Cairns; W R Green; H S Singer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1984       Impact factor: 3.117

10.  Lysosomal alpha-N-acetylgalactosaminidase deficiency, the enzymatic defect in angiokeratoma corporis diffusum with glycopeptiduria.

Authors:  T Kanzaki; A M Wang; R J Desnick
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.